Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Samaras P, Buset EM, Siciliano RD, Haile SR, Petrausch U, Mischo A, Honegger H, Pestalozzi BC, Schanz U, Stussi G, Stahel RA, Knuth A, Renner C, Stenner-Liewen F. Samaras P, et al. Among authors: petrausch u. Oncology. 2010;79(1-2):93-7. doi: 10.1159/000320604. Epub 2010 Nov 15. Oncology. 2010. PMID: 21079406 Free article.
[After care in Hodgkin lymphoma].
Petrausch U, Samaras P, Mischo A, Stenner F, Tinguely M, Schäfer N, Studer G, Renner C. Petrausch U, et al. Praxis (Bern 1994). 2011 Dec 14;100(25):1515-20; quiz 1521-2. doi: 10.1024/1661-8157/a000744. Praxis (Bern 1994). 2011. PMID: 22161876 German. No abstract available.
Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial.
Hiltbrunner S, Britschgi C, Schuberth P, Bankel L, Nguyen-Kim TDL, Gulati P, Weder W, Opitz I, Lauk O, Caviezel C, Bachmann H, Tabor A, Schröder P, Knuth A, Münz C, Stahel R, Boyman O, Renner C, Petrausch U, Curioni-Fontecedro A. Hiltbrunner S, et al. Among authors: petrausch u. Ann Oncol. 2021 Jan;32(1):120-121. doi: 10.1016/j.annonc.2020.10.474. Epub 2020 Oct 21. Ann Oncol. 2021. PMID: 33098996 Free article. Clinical Trial. No abstract available.
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.
Samaras P, Blickenstorfer M, Siciliano RD, Haile SR, Buset EM, Petrausch U, Mischo A, Honegger H, Schanz U, Stussi G, Stahel RA, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Among authors: petrausch u. Ann Hematol. 2011 Jan;90(1):89-94. doi: 10.1007/s00277-010-1036-8. Epub 2010 Aug 13. Ann Hematol. 2011. PMID: 20706722
Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience.
Samaras P, Blickenstorfer M, Haile SR, Siciliano RD, Petrausch U, Mischo A, Zweifel M, Honegger H, Schanz U, Stussi G, Taverna C, Bauer S, Knuth A, Stenner-Liewen F, Renner C. Samaras P, et al. Among authors: petrausch u. Swiss Med Wkly. 2011 May 31;141:w13203. doi: 10.4414/smw.2011.13203. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21630163 Free article.
Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation.
Samaras P, Zardavas D, Petrausch U, Buset EM, Haile SR, Honegger H, Siciliano RD, Schanz U, Mischo A, Schäfer NG, Taverna C, Knuth A, Stahel R, Renner C, Stenner-Liewen F. Samaras P, et al. Among authors: petrausch u. Swiss Med Wkly. 2013 May 7;143:w13791. doi: 10.4414/smw.2013.13791. eCollection 2013. Swiss Med Wkly. 2013. PMID: 23740138 Free article. No abstract available.
60 results